mergers-and-acquisitions News
Merck in Talks to Acquire Revolution Medicines for Up to $32 Billion
A deal would be a major strategic bet on next-generation oncology to bolster Merck's pipeline as its blockbuster drug Keytruda faces patent expiration.
Merck Eyes $32B Deal for Revolution Medicines, Stock Soars
Potential acquisition would be a major move to bolster Merck's oncology pipeline as its blockbuster Keytruda faces future patent cliffs. RVMD shares surged on the news.
OneStream to Be Taken Private by Hg Capital in $6.4 Billion Deal
Shares climb toward the $24 offer price as analysts downgrade the software firm, citing limited upside potential post-acquisition.
JPMorgan to Acquire Apple Card Portfolio From Goldman Sachs
The deal will see JPMorgan take on roughly $20 billion in credit card balances, marking a decisive exit for Goldman from its high-profile but troubled consumer banking venture.
Revolution Medicines Stock Soars on AbbVie Acquisition Talks
Shares of the cancer drug developer surged nearly 29% after reports that pharmaceutical giant AbbVie is nearing a deal to acquire the company, potentially valuing it around $20 billion.
Amgen Shares Climb on $840 Million Leukemia Drug Bet
The acquisition of Dark Blue Therapeutics adds a promising preclinical asset to Amgen's oncology pipeline, signaling a deeper push into targeted cancer therapies.
Ventyx Biosciences Stock Soars 37% on Eli Lilly Takeover Reports
The pharmaceutical giant is reportedly in advanced talks for a deal valued at over $1 billion, aiming to acquire Ventyx's promising autoimmune drug pipeline.
D-Wave to Acquire Quantum Circuits in $550M Power Play
The deal unites D-Wave's pioneering annealing technology with QCI's gate-model expertise, aiming to accelerate the development of error-corrected quantum computers.